A new inhaler — Synchrobreathe — designed to manage Obstructive Airway Disease (OAD) has been launched. It is an innovation in managing respiratory disease. Approximately 90% of physicians in India reported prescribing inhaler devices to at least 40% of their asthma and COPD patients in the first clinic visit. Educating patients on the benefits of inhalation therapy and the correct inhaler technique can help increase the acceptance, adherence and correct usage of inhalers, which can result in better disease control.
In New Delhi, chronic respiratory disease is the number one leading cause of death in the 15-39 year age group and the third leading cause of death in the 40-69 year age group. Further, COPD has moved from the thirteenth leading cause of death and disability in 1990 to the third leading cause in 2016. This shows the growing burden of respiratory disease and the burning need to control it,” Dr Karan Madan, Assistant Professor, Department of Pulmonary Medicine and Sleep Disorders, AIIMS, said.
Inhaled medicines are integral to the management of respiratory diseases like asthma and COPD. They deliver drugs directly to the lungs and hence act faster and at a lower dose, thereby reducing the risk of side effects. Inhaled medications have been shown to improve disease status, control symptoms, reduce the number and severity of exacerbations and improve quality of life.
